Peptide Research Goals: Browse by Therapeutic Area | PeptideGuide

Inflammation / Anti-Inflammatory

wpx_ — Thu, 02 Apr 2026 16:37:52 +0000

Peptides researched for anti-inflammatory mechanisms, cytokine modulation, and inflammatory pathway regulation. This goal page collects compounds investigated for their ability to reduce pathological inflammation through diverse molecular targets.

Anti-inflammatory research in this category spans NF-κB pathway modulation (KPV, GHK-Cu), innate repair receptor activation (ARA-290), mitochondrial protection reducing inflammatory cascades (SS-31), antimicrobial peptides with immunomodulatory dual roles (LL-37, thymosin alpha-1), and broad-spectrum tissue protectants (BPC-157, cortexin) with anti-inflammatory components in their mechanism profiles.

Gut Health / GI Support

wpx_ — Thu, 02 Apr 2026 16:37:51 +0000

Peptides researched for gastrointestinal protection, mucosal healing, gut barrier integrity, and digestive function. This goal page collects compounds investigated for their effects on the GI tract, from gastric cytoprotection to intestinal anti-inflammatory signalling.

The peptides in this category include BPC-157 (a gastric pentadecapeptide with extensive GI preclinical data), KPV (an alpha-MSH fragment with colitis research), LL-37 (a cathelicidin with antimicrobial gut-defence research), and oxytocin (with emerging gut motility and microbiome interaction data).

Immune Support / Immunomodulation

wpx_ — Thu, 02 Apr 2026 16:37:51 +0000

Peptides researched for immune system modulation, spanning innate immunity activation, adaptive immune regulation, and immunorestoration. This goal page collects compounds investigated for their effects on immune cell function, cytokine balance, and host defence mechanisms.

Research in this area ranges from thymic peptides (thymalin, thymosin alpha-1) that support immune reconstitution, to antimicrobial peptides (LL-37, KPV) with direct host-defence roles, to tissue-protective agents (ARA-290) whose immune-modulatory effects are secondary to cytoprotective signalling.

Cognitive & Nootropic Support

wpx_ — Thu, 02 Apr 2026 02:34:43 +0000

Peptides researched for cognitive enhancement, nootropic effects, and neurotrophic signalling. This goal page collects compounds investigated for BDNF upregulation and synaptic plasticity (semax, dihexa), anxiolytic-cognitive peptides (selank), cholinergic and neuropeptide modulation (NA-Semax, cortexin), and cerebrolysin’s neurotrophic factor cocktail — spanning preclinical memory and learning models through to clinical cognitive-assessment data.

Neuroprotection

wpx_ — Thu, 02 Apr 2026 02:34:42 +0000

Peptides researched for neuroprotective mechanisms, neuronal survival, and central-nervous-system resilience. This goal page collects compounds investigated for protection against neurodegeneration (cerebrolysin, dihexa), mitochondrial rescue in neural tissue (SS-31, humanin), anti-inflammatory neuroprotection (cortexin, ARA-290), and bioregulatory peptides (pinealon, epithalon) with preclinical CNS data spanning traumatic brain injury, ischaemic stroke, and age-related cognitive decline models.

Libido & Sexual Function

wpx_ — Mon, 30 Mar 2026 06:36:17 +0000

Peptides researched for libido, sexual function, and arousal-pathway signalling. This goal page collects compounds investigated for melanocortin-receptor mediated arousal (PT-141/bremelanotide — the only peptide in this category with FDA approval for HSDD), alongside kisspeptin’s emerging role in sexual-arousal processing and GH-axis peptides with secondary libido-related endpoints in clinical observation.

Metabolic Health / Insulin Sensitivity

wpx_ — Mon, 30 Mar 2026 06:36:13 +0000

Peptides researched for glucose homeostasis, insulin sensitivity, and metabolic-health optimisation. This goal page collects incretin-based therapies (semaglutide, tirzepatide, dulaglutide, exenatide) with glycaemic control as a primary endpoint, alongside GH-axis compounds (tesamorelin, CJC-1295) and mitochondrial peptides (SS-31, humanin) with secondary metabolic data in preclinical and clinical models.

Appetite & Weight Management

wpx_ — Mon, 30 Mar 2026 06:36:11 +0000

Peptides researched for appetite regulation, satiety signalling, and weight-management support. This goal page collects GLP-1 receptor agonists (semaglutide, liraglutide, exenatide), dual and triple incretin agonists (tirzepatide, retatrutide, cagrilintide), and emerging oral peptide alternatives (danuglipron, orforglipron) — spanning Phase III weight-loss trial data through to preclinical appetite-centre research.

Injury & Tissue Support

wpx_ — Mon, 30 Mar 2026 06:36:08 +0000

Peptides researched for injury recovery, soft-tissue repair, and wound-healing acceleration. This goal page collects compounds investigated for tendon, ligament, and connective-tissue support (BPC-157, TB-500), growth-factor mediated tissue remodelling (IGF-1 LR3, PEG-MGF), and anti-inflammatory repair cascades — spanning preclinical injury models through to clinical orthopaedic and surgical-recovery data.

Longevity / Healthy Aging

wpx_ — Mon, 30 Mar 2026 06:21:14 +0000

Peptides researched for healthy-aging mechanisms, cellular resilience, and longevity-associated pathways. This goal page collects compounds investigated for mitochondrial protection (SS-31, humanin), telomerase modulation (epithalon), senolytic-adjacent signalling (FOXO4-DRi), thymic regeneration (thymalin), and NAD⁺-pathway interactions — spanning preclinical lifespan data through to clinical biomarker studies.